An urgent nationwide health alert has been triggered after health authorities discovered a popular antibacterial soap contaminated with potentially deadly bacteria. The Medicines and Healthcare products Regulatory Agency (MHRA) has expanded its recall of Dermarite soap products following the detection of Burkholderia cepacia complex.
Immediate Health Risk Identified
The contamination poses a severe threat to vulnerable populations, particularly those with compromised immune systems, cystic fibrosis patients, and individuals with chronic lung conditions. The Burkholderia cepacia bacteria can cause serious respiratory infections that may prove fatal in high-risk groups.
Full List of Affected Products
The expanded recall now includes multiple batches of Dermarite antibacterial soap bars distributed across the United Kingdom. Consumers are urged to immediately check their bathrooms for the following products:
- Dermarite Antibacterial Soap Bar 100g
- All batch codes with expiration dates through 2025
- Products purchased within the last 12 months
Official Safety Instructions
The MHRA has issued clear guidelines for consumers who may have purchased the contaminated products:
- Stop using the soap immediately if you have any Dermarite products
- Return the product to the place of purchase for a full refund
- Seek medical attention if you have experienced any unusual symptoms
- Do not attempt to use the product even if symptoms haven't appeared
Symptoms to Watch For
Health officials warn that exposure to the contaminated soap could lead to:
- Persistent respiratory infections
- Pneumonia-like symptoms
- Fever and chills
- Difficulty breathing in severe cases
National Distribution Concerns
The products were distributed through major pharmacy chains and online retailers across England, Scotland, Wales, and Northern Ireland. The widespread availability of these products has prompted health authorities to issue this urgent nationwide warning.
Healthcare professionals have been alerted to monitor for potential cases of infection, particularly among vulnerable patient groups who may have used the contaminated soap products.
